Margolis Center leaders told the Academic Council last week that the next step for the center is to become an institute to help raise Margolis’ external reputation, recruit new faculty and grow its educational efforts.

Mary Klotman, MD, Talks with Kanecia Zimmerman, MD, PhD, MPH, who is Duke's principal investigator for the Clinical Trials Data Coordinating Center for research on Long COVID.

Sifting through information can be overwhelming. But open access journals are changing the game, offering quality articles for free online. Duke Medical Library kicks off International Open Access Week (Oct. 23-29), celebrating its bold step to cover publishing fees in some journals for Duke scholars.

A vaccine designed to protect against three different deadly coronaviruses shows success in mouse studies, demonstrating the viability of a pan-coronavirus vaccine developed by researchers at the Duke Human Vaccine Institute.

Mary E. Klotman, MD, Executive Vice President for Health Affairs, Duke University; Dean, Duke University School of Medicine, and Chief Academic Officer, Duke Health and Craig Albanese, MD, MBA, Chief Executive Officer, Duke University Health System detail how they're working together to build deeper alignment between Duke’s clinical, academic, research and global health missions, and establish a unified system in which each part enhances the other.

The School of Medicine’s new employee resource group ¡DALHE! Kicked off its inaugural event recognizing Hispanic Heritage Month on Friday, October 6.

Everardo Macias's quest to find innovative treatments for prostate cancer mirrors his own incredible journey – from a migrant farm worker to a groundbreaking scientist.

Immunologists identify a pivotal protein in the progression of MS. Could blocking it be the future of treatment?

A host of luminaries, including seven Nobel Laureates, two former chancellors, and scores of Robert J. Lefkowitz’s former trainees gather to celebrate his 50 years at Duke.

Research finds younger African American women with triple-negative breast cancer may have a molecularly distinct form of the disease that makes it more aggressive.